Effectiveness of Trauma Therapy Using Prolonged Exposure for Patients With PTSD and a Comorbid Psychotic Disorder (TEP)
Post Traumatic Stress Disorder, PTSD, Psychosis
About this trial
This is an interventional treatment trial for Post Traumatic Stress Disorder focused on measuring PTSD, schizophrenia, Prolonged Exposure
Eligibility Criteria
Inclusion Criteria: Presence of a psychotic disorder (F20) or affective disorder with psychotic symptoms(F30) according to DSM-5. comorbid post-traumatic stress disorder (PTSD) according to DSM-5 (CAPS-5 score ≥ 23) At least 18 years old Good knowledge of the German language Willingness to participate in randomisation and trauma-focused therapy Exclusion Criteria: Changes in neuroleptic or antidepressant therapy within the last 4 weeks (exclusion of drug effects). Any substance dependence with continued use other than nicotine and/or caffeine dependence. IQ of 70 or less Acute suicidality Pregnant women
Sites / Locations
- Medicalschool HamburgRecruiting
Arms of the Study
Arm 1
Arm 2
No Intervention
Experimental
Waiting control group
Intervention group
The patients in the treatment-as-usual control group remain on the waiting list for 14 weeks after the baseline measurement. After 14 weeks, they participate in the study diagnostics post-treatment at time point.
In the intervention condition, patients are treated directly after the baseline measurement by Prolonged Exposure in 16 hours of individual therapy. The 16 individual therapy sessions will take place in 1 to 2 sessions per week over a period of 7 to 16 weeks. The individual therapy sessions are videotaped with camera focus on the therapist. Parts of the Prolonged Exposure process (the re-experiencing of the traumatic memory) are recorded on tape, so that the patient can listen to the recording as homework at home. Afterwards, the patients take part in a study diagnostic session.